A Biotech I have mentioned here before with great fundamentals.. folks may want to take a gander at it.....this is a volatile pup....been in the .50's and above $10....very little known company with an excellent service....currently they are growing very nicely as you can see by the numbers...they have no debt and alot of cash, but best of all, they are number one in their sector, and it's an untapped sector, with high growth extremely possible....just imagine if maternity insurance covers this very cheap, affordable and beneficial service.....right now, they are tapping into less then 1% of market...what happens when more and more people find out about this great service, and if insurance covers it...and even if it doesnt....$200 one time fee, and then like $90 a year for storage...pretty darned cheap when it comes to the health and well being of your child....already, several documented cases of children with terminal illnesses, that have been 100% cured, due to the fact cells were available....All I know is if it comes to your child, and you can spend so little to store the cells, and no harm can come of it, and only good...well, I think as more and more people that find out about this service and the miracles that have already happened.....you tell me if high growth is a possibility...
<<CRYO-CELL Announces Deployment of America`s First Dual Location U-Cord(TM) Back-Up Storage Program
November 12, 2002 15:33:00 (ET)
CLEARWATER, Fla., Nov 12, 2002 /PRNewswire-FirstCall via COMTEX/ -- CRYO-CELL International, Inc. (CCEL, Trade) today announced a new premium service that will provide clients with extra protection for incoming U-Cord specimens by storing a portion of harvested stem cells located at the Company's facility in Clearwater, Florida and the balance of collected specimens at the premier Safti-Cell facility located in Arizona.
This new CRYO-CELL service will provide clients with redundant storage protection at a 20% discount on the annual fee for specimens stored at Safti- Cell. The total annual fee for dual location storage is $90. "We are excited to offer additional peace of mind to new CRYO-CELL clients with this value- added service," said John V. Hargiss, President and Chief Executive Officer. "Although our new service will not be available to existing clients who have cryo-preserved specimens stored at CRYO-CELL, we have made significant enhancements to our physical structure, security systems and procedures. These additions include installation of interior and exterior steel hurricane shutters, multiple state-of-the-art security networks, 24 X 7 video surveillance cameras and a back-up emergency power generator. All of these measures are designed to heighten the safekeeping of the Company's headquarters storage facility. These enhancements, along with the new Safti- Cell service, are indicative of our commitment to continually improve product quality."
According to Charles D. Nyberg, President of Safti-Cell, "Safti-Cell service will afford the greatest protection for clients preserving the precious U-Cord stem cells of newborns. Through our back-up storage program, concerns about natural or man-made disasters are mitigated."
The Company also reported $648K in revenues for October 2002 versus $578K in 2001, resulting in the second highest monthly revenues from the Company's core business of processing and preserving umbilical cord blood. Year-to-date revenues for 2002 are $6.5 MIL versus year-to-date revenues of $5.1 MIL for 2001, representing an increase of 27% for the same period over last year. Year-to-date 2001 revenues included $750,000 from the sale of a Revenue Sharing Agreement. Year-to-date 2002 revenues from U-Cord processing and preservation only are $6.5 MIL versus year-to-date comparable revenues of $4.4 MIL for 2001, representing a 48% year-over-year increase.
"The combination of expanded marketing initiatives, globalization opportunities and the introduction of the new, value-added Safti-Cell service position CRYO-CELL to achieve sustainable top-line growth," commented John Hargiss. "With our vigilant priority on improving operating efficiencies, CRYO-CELL is well-poised to further enhance shareholder value."
Based in Clearwater, Florida, CRYO-CELL is now the world's largest and fastest-growing U-Cord(TM) stem cell banking firm, offering affordable cord blood storage exclusively for the benefit of newborn babies and possibly other members of their family. CRYO-CELL has pioneered America's most affordable U- Cord preservation program. Web site www.cryo-cell.com.
CRYO-CELL is a publicly traded company. Nasdaq Symbol ... CCEL.
Forward-Looking Statement
Statements wherein the terms "believes," "intends," "projects" or "expects" as used are intended to reflect "forward-looking statements" of the Company. The information contained herein is subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements or paragraphs. Readers should carefully review the risk factors described in other documents the Company files from time to time with the Securities and Exchange Commission, including the most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K filed by the Company.
Make Your Opinion Count - Click Here
tbutton.prnewswire.com
SOURCE CRYO-CELL International, Inc.
Jill Taymans of CRYO-CELL International, Inc., +1-727-723-0333,
or fax, +1-727-723-0444, or investor.relations@cryo-cell.com
/Photo: newscom.com
AP Archive: photoarchive.ap.org
PRN Photo Desk, 888-776-6555 or 212-782-2840 >> |
